Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970512 · ClinicalTrials.gov registry record · NA
Apioc Toric/Spherical Single Vision Contact Lens
A NA study, sponsored by Lentechs.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03970512 is a NA study that has completed, run by Lentechs. The registered enrollment target is 51 participants.
The verdict
NCT03970512, a NA study, has completed, sponsored by Lentechs.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior position. Unlike contact lenses currently on the market, this innovative design improves lens stability by preventing lens rotation, and may improve tear flow behind the lens.
Interventions
- DEVICE Apioc-A and Apioc-S Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-05-31 |
| Est. Completion | 2021-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970512
The ClinicalTrials.gov registry entry for NCT03970512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lentechs, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Apioc-A and Apioc-S Contact Lenses is the first listed.
NCT03970512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03970512 about?
NCT03970512 is a clinical study titled "Apioc Toric/Spherical Single Vision Contact Lens". The Lentechs Apioc-S and Apioc-A contact lenses are made in an FDA-approved contact lens material indicated for single-vision and astigmatism. The novel lens design has a lenticular portion which is thicker than the optical portion of the lens. When applied to the eye, it is oriented in a superior p...
What is the current status of trial NCT03970512?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2019-05-31. Estimated completion is 2021-03-18.
What interventions are being tested in trial NCT03970512?
The interventions under investigation include: Apioc-A and Apioc-S Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT03970512?
This trial is sponsored by Lentechs, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.